Back

Johnson & Johnson shares rise 1.3% as Apollo weighs $20 billion orthopedics deal

Verifying
  • Apollo Global Management is discussing a potential purchase of Johnson & Johnson’s orthopedics unit.
  • Nearly $20 billion could be the division’s valuation in a potential transaction.
  • The orthopedics unit generated $9.3 billion in revenue during 2025.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.